<DOC>
	<DOC>NCT01796145</DOC>
	<brief_summary>In patients with inoperable HCC undergoing non-surgical therapy as first-line therapy 1. We aim to determine the prognostic significance of liver stiffness in patients with HCC 2. We aim to determine the rate and severity of complications of treatment and its association with liver stiffness in patients with HCC</brief_summary>
	<brief_title>Fibroscan Study in HCC</brief_title>
	<detailed_description />
	<criteria>Clinical diagnosis of inoperable HCC Patients who are scheduled to undergo nonsurgical therapy, either TACE or systemic therapy 1. For TACE cohort, patients undergoing first cycle TACE are eligible. 2. For systemic therapy cohort, patients undergoing firstline systemic therapy are eligible. Prior surgery or locoablative therapy (e.g. Radiofrequency ablation, microwave, percutaneous ethanol injection) is allowed Child's A or Child's B liver function Child's C liver function ECOG performance status &gt; 2 Poorly controlled ascites</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>